Prognostic factors for late mortality after liver transplantation for benign end-stage liver disease.
- Author:
Ying-Cai ZHANG
1
;
Qi ZHANG
;
Hua LI
;
Jian ZHANG
;
Gen-Shu WANG
;
Chi XU
;
Shu-Hong YI
;
Hui-Min YI
;
Chang-Jie CAI
;
Min-Qiang LU
;
Yang YANG
;
Gui-Hua CHEN
Author Information
- Publication Type:Journal Article
- MeSH: End Stage Liver Disease; mortality; surgery; Hepatitis B; mortality; Humans; Liver Transplantation; Postoperative Complications; mortality; Retrospective Studies
- From: Chinese Medical Journal 2011;124(24):4229-4235
- CountryChina
- Language:English
-
Abstract:
BACKGROUNDThere are increasing numbers of patients who survive more than one year after liver transplantation. Many studies have focused on the early mortality of these patients. However, the factors affecting long-term survival are not fully understood. This study aims to evaluate prognostic factors predicting long-term survival and to explore measures for improving the survival outcomes of patients who underwent liver transplantation for benign end-stage liver diseases.
METHODSThe causes of late death after liver transplantation and potential prognostic factors were retrospectively analyzed for 221 consecutive patients who underwent liver transplantation from October 2003 to June 2008. Twenty-seven variables were assessed using the Kaplan-Meier method, and those variables found to be univariately significant at P < 0.10 were entered into a backward step-down Cox proportional hazard regression analysis to identify the independent prognostic factors influencing the recipients' long-term survival.
RESULTSTwenty-eight recipients died one year after liver transplantation. The major causes of late mortality were infectious complications, biliary complications, and Hepatitis B virus recurrence/reinfection. After Cox analysis, the five remaining co-variables were: age, ABO blood group, cold ischemia time, post-infection region, and biliary complications.
CONCLUSIONSThe major causes of late mortality were infection, biliary complications and Hepatitis B virus recurrence/reinfection. Five variables (Age, ABO blood group, cold ischemia time, infection, and biliary complications) had significant impacts on patient survival.